Atlas Trials

Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder

Clinical trial NCT05457465 · RECRUITING

Trial details

NCT number
NCT05457465
Sponsor
Mclean Hospital
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Bipolar Disorder
Start date
2023-06-01
Primary completion
2026-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.